Ultraverse® 035 PTA Dilatation Catheter U35130615Recalls & reported problems
Bard Peripheral Vascular, Inc. · Ultraverse 035 PTA Dilatation Catheter 6.0mm x 150mm balloon, 130cm shaft · Class 2
All models of Ultraverse 035 PTA Dilatation Catheter (92)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00801741093227), received between Aug 20, 2018 and Oct 15, 2024 — classified as 2 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Material Rupture” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Material Rupture2
- Device-Device Incompatibility1
- Difficult to Insert1
- Difficult to Remove1
Patient problems
- No Consequences Or Impact To Patient2
- Vascular Dissection2
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryOct 15, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH THE RESULTS OF THE CLINICAL TRIAL THAT DURING PRE-DILATATION OF THE LEFT LEG TARGET LESION STENOSIS ON THE SUPERFICIAL FEMORAL ARTERY USING ULTRAVERSE BALLOON CATHETER, THE SUBJECT HAD AN ADVERSE EVENT OF DISSECTION. REPORTEDLY, THE ADVERSE EVENT WAS NOT RELATED TO THE STUDY DEVICE BUT CAUSAL RELATIONSHIP TO THE STUDY PROCEDURE. THE OUTCOME OF THE ADVERSE EVENT WAS RECOVERED. HOWEVER, THE CURRENT STATUS OF THE PATIENT WAS UNKNOWN.
Patient problems: Vascular Dissection
MAUDE report 20450305 ↗InjurySep 23, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH THE RESULTS OF THE CLINICAL TRIAL THAT DURING PRE-DILATATION OF THE LEFT LEG TARGET LESION STENOSIS ON THE SUPERFICIAL FEMORAL ARTERY USING ULTRAVERSE BALLOON CATHETER, THE SUBJECT HAD AN ADVERSE EVENT OF DISSECTION. REPORTEDLY, THE ADVERSE EVENT WAS NOT RELATED TO THE STUDY DEVICE BUT CAUSAL RELATIONSHIP TO THE STUDY PROCEDURE. THE OUTCOME OF THE ADVERSE EVENT WAS RECOVERED. HOWEVER, THE CURRENT STATUS OF THE PATIENT WAS UNKNOWN.
Patient problems: Vascular Dissection
MAUDE report 20277514 ↗MalfunctionOct 18, 2022Difficult to Insert; Difficult to Remove; Device-Device Incompatibility; Difficult to Insert; Difficult to Remove; Device-Device Incompatibility
IT WAS REPORTED THAT DURING AN ANGIOPLASTY IN THE DISTAL SFA, THE BALLOON ALLEGEDLY HAD DIFFICULTY IN INTRODUCING TO THE SHEATH . IT WAS FURTHER REPORTED THAT THE DEVICE WAS DIFFICULT TO REMOVE. THE PROCEDURE WAS COMPLETED USING ANOTHER DEVICE. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15624733 ↗MalfunctionApr 15, 2020Material Rupture; Material Rupture
THIS REPORT SUMMARIZES ONE MALFUNCTION. A REVIEW OF THE REPORTED INFORMATION INDICATED THAT MODEL U35130615 PTA BALLOON DILATATION CATHETER ALLEGEDLY EXPERIENCE MATERIAL RUPTURE. THIS REPORT WAS RECEIVED FROM A SINGLE SOURCE. THIS EVENT DID INVOLVE PATIENT WITH NO PATIENT CONSEQUENCES. AGE, WEIGHT, AND GENDER WERE NOT PROVIDED FOR THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9965230 ↗MalfunctionAug 20, 2018Material Rupture; Material Rupture
IT WAS REPORTED THAT DURING AN ANGIOPLASTY PROCEDURE OF A HIGHLY CALCIFIED LESION IN THE ILIAC ARTERY, THE PTA BALLOON ALLEGEDLY RUPTURED ON THE SECOND INFLATION ATTEMPT PRIOR TO REACHING RATED BURST PRESSURE. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7799644 ↗
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page